Document is current
Any future updates will be listed below
-
Authors
Jang, Sung Ill
Lee, Hyung Keun
Chang, Eun-Ju
Kim, Somi
Kim, So Young
Hong, In Young
Kim, Jong Kyoung
Lee, Hye Sun
Yang, Juyeon
Cho, Jae Hee
Lee, Dong Ki https://orcid.org/0000-0002-0048-9112
-
Clinical Trials BETA
Clinical trials referenced in this document:
kct0004614 at Clinical Research Information Service, Republic of KoreaDocuments that mention this clinical trial
Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing
https://doi.org/10.1007/s00262-023-03458-8
-
Funding
Funding for this research was provided by:
The Technology Development Program (S3301290, S3301290)
- License Information
-
More Information
Article History
Received: 7 March 2023
Accepted: 26 April 2023
First Online: 10 May 2023
Declarations
:
: The authors disclose their financial interests as follows. Authors S.-I.J., E.-J.C., S.K., J.-K.K. H.-S.L., J.-Y.Y., J.-H.C., and D.-K.L. report no financial interests. Author H.-K.L. serves on the board of directors of AccurasysBio Co., Ltd. but does not receive any compensation as a member of the board of directors. Authors S.-Y.K. and I.-Y.H. receive salaries from AccurasysBio Co., Ltd.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Gangnam Severance Hospital (IRB No. 3-2018-0293, 3-2020-0238).
: Informed consent was obtained from all subjects involved in the study.
: The authors confirm that all research participants provided informed consent for publication.
